The ROC curves of each index before the initiation of anti-TB treatment and after 6 months of anti-TB treatment were drawn, and the AUCs indicated the expression of CD27− and CD27−CD38+ in IFN-γ+CD4+ T cells might be potential markers to distinguish patients with active TB before and after treatment. The gene discussed is CD4; the disease is tuberculosis.